Bioxcel Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $41k | 15k | 2.79 |
| 2023-12-31 | $82k | 28k | 2.95 |
| 2023-09-30 | $18k | 7.7k | 2.41 |
| 2023-06-30 | $671k | 101k | 6.66 |
| 2023-03-31 | $1.0M | 56k | 18.65 |
| 2022-12-31 | $111k | 5.1k | 21.61 |
| 2022-09-30 | $10k | 811 | 12.33 |
| 2022-06-30 | $33k | 2.4k | 13.53 |
| 2022-03-31 | $61k | 2.9k | 21.11 |
| 2021-12-31 | $426k | 21k | 20.35 |
| 2021-09-30 | $314k | 10k | 30.36 |
| 2021-06-30 | $172k | 5.9k | 29.14 |
| 2020-12-31 | $22k | 480 | 45.83 |
| 2020-09-30 | $1.2M | 29k | 43.34 |
| 2020-06-30 | $32k | 600 | 53.33 |
| 2019-12-31 | $101k | 6.9k | 14.56 |
| 2019-09-30 | $21k | 3.0k | 7.07 |
| 2019-06-30 | $43k | 3.9k | 11.07 |
| 2018-03-31 | $6.3M | 618k | 10.24 |